Trials / Conditions / Brain Metastases From Solid Tumors
Brain Metastases From Solid Tumors
6 registered clinical trials studyying Brain Metastases From Solid Tumors — 5 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Not Yet Recruiting | SMART Trial: Cognitive Sparing Brain Radiotherapy for Multiple Brain Metastases NCT07505979 | National Taiwan University Hospital | Phase 2 |
| Not Yet Recruiting | Evaluating Biomarkers of Cognitive Dysfunction in Patients With Cancer NCT07226466 | University of California, San Francisco | — |
| Recruiting | Phase 2b Imaging Study of RAD101 in Participants With Suspected Recurrent Brain Metastases NCT06777433 | Radiopharm Theranostics, Ltd | Phase 2 |
| Recruiting | A Phase 1/1b Study of IAM1363 in HER2 Cancers NCT06253871 | Iambic Therapeutics, Inc | Phase 1 |
| Recruiting | A First-In-Human, Phase 1 Study Evaluating Oral TACC3 PPI Inhibitor, AO-252, in Advanced Solid Tumors With or NCT06136884 | A2A Pharmaceuticals Inc. | Phase 1 |
| Completed | 131I-L19SIP Radioimmunotherapy (RIT) in Combination With External Beam Radiation in Patients With Multiple Bra NCT01125085 | Philogen S.p.A. | Phase 2 |